Regional Differences in Adaptation of CNS Mu Opioid Receptors to Chronic Opioid Agonist Administration
Journal:
Current Neuropharmacology
Volume:
3
Page:
157-182
Author(s):
L. J. Sim-Selley
Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1353-1389
Author(s):
Hari Shanker Sharma
What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Journal:
Current Gene Therapy
Volume:
5
Page:
151-165
Author(s):
David S. Strayer, Pierre Cordelier, Rumi Kondo, Bianling Liu, Alexey A. Matskevich, Hayley J. McKee, Carmen N. Nichols, Christine B. Mitchell, Dawn A. Geverd and Martyn K. White
Cancer Gene Therapy Utilizing Interleukin-13 Receptor α2 Chain
Journal:
Current Gene Therapy
Volume:
5
Page:
213-223
Author(s):
Koji Kawakami
Adenovirus-mediated Transgene-engineered Dendritic Cell Vaccine of Cancer
Journal:
Current Gene Therapy
Volume:
5
Page:
237-247
Author(s):
Qiaohua Wu, Dajing Xia, Svein Carlsen and Jim Xiang
Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1105-1117
Author(s):
M. Folini and N. Zaffaroni
Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1167-1180
Author(s):
A. Nagy and A. V. Schally
Autologous Formalin-Fixed Tumor Vaccine
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1181-1188
Author(s):
T. Ohno
Somatostatin: A Hormone for the Heart?
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
125-131
Author(s):
Amy C. Badway and Allan D. Blake
Studies on Target Genes of General Anesthetics-Version 2
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
97-109
Author(s):
Sumiko Gamo